Amgen Inc. Researchers Provide New Insights into Atopic Dermatitis (NLRP10 maintains epidermal homeostasis by promoting keratinocyte survival and P63-dependent differentiation and barrier function).

Předmět:
Zdroj: Genomics & Genetics Weekly; 11/8/2024, p161-161, 1p
Abstrakt: Researchers from Amgen Inc. have published a study on atopic dermatitis, a chronic inflammatory skin disorder. The study highlights the role of NLRP10 in promoting keratinocyte survival, epidermal differentiation, and barrier function. The findings suggest that NLRP10 could be a potential target for therapeutic intervention to restore skin barrier function in atopic dermatitis. [Extracted from the article]
Databáze: Complementary Index